Investment, Funding & Disinvestments

The PEN-Plus strategy strengthens local hospitals to diagnose and manage complex illnesses requiring continuous care.

The acquisition centers on Alcyone’s innovative ThecaFlex DRx drug delivery system, an experimental implantable device that represents a significant advancement in treating neurological disorders.

Construction at the MTC is currently underway and is scheduled for completion during the first half of 2027.

This project marks the first hospital of its kind in the Gulf region, blending medical excellence with advanced urban planning.

The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).

The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.

This new facility will replace the existing laboratory, which Minister of Agriculture and Animal Resources Mark Cyubahiro Bagabe noted has served for nearly four decades and no longer meets current needs.

Through this partnership, Merck gains access to Valo’s advanced AI-powered human causal biology and discovery platforms, which the drugmaker will use to identify new disease targets and develop preclinical compounds.

The new facility will produce molecules for medical trials. These expansions will create 200 additional jobs in Frederick and 100 more in Gaithersburg.